Asoy, Roldan Y.
HRN: 20-15-90 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/12/2022
12/18/2022
IVT
1.5g
Q6
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes